Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

CNS Anticancer Drug Discovery and Development White Paper

View article to download PDF copy

Read Full Story

New Consensus Recommendations Announced for Standardized Imaging Protocol in Brain Tumor Clinical Trials

Brain Tumor Imaging Protocol Will Reduce Variability in Magnetic Resonance Imaging and Increase Accuracy in ...

Read Full Story

SNO Pre-Conference Sessions

November 18 - 19, San Antonio, Texas immediately preceding the SNO Annual Meeting

Read Full Story
View All News


XXII World Congress of Neurology

Read Full Story


SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

Read Full Story


Neuro-Oncology Review Course

Read Full Story

Neuro-Oncology Impact Factor Rises

The Society for Neuro-Oncology is pleased to announce that the impact factor for Neuro-Oncology has risen to 6.180, putting the journal among the top ten titles in Clinical Neurology by the Science Citation Index.

This new, higher ranking reinforces Neuro-Oncology’s position as the leading journal in the field.

With a wealth of peer-reviewed articles and reviews, topical symposia, abstracts of annual meetings, and society news from around the world, the journal continues its mission to provide superior and rapid publication of information in all areas of neuro-oncology.

The three recent most highly cited papers are free to read via the below links.


Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

Authors: de Groot, John F.; Fuller, Gregory; Kumar, Ashok J.; et al.


A multigene predictor of outcome in glioblastoma

Authors: Colman, Howard; Zhang, Li; Sulman, Erik P.; et al.


A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

Authors: Raizer, Jeffrey J.; Abrey, Lauren E.; Lassman, Andrew B.; et al.


For more information